Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its ‘Solid’ Quarterly Report
Investor's Business DailyAbbott Laboratories came in Wednesday with a “solid” first-quarter report that included a guidance raise, but Abbott stock slipped.
The post Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report appeared first…